TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Drug abuse preventive behaviors
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: 24-month Overall Survival rates
Endpoint domain: Mortality/survival
Primary endpoint: Treatment-related Adverse Events (TRAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Achieving modified MDA response after 12 weeks of adalimumab treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Snoring duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of stage N3 sleep (%N3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep outcomes
Primary endpoint: Adherence to HEPs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Proportion of stent dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Urinary sodium/cGMP excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: perioperative outcomes and complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Increases in muscle volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Twitch peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Angle of pennation of the VM
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Pain and discomfort during active orthodontic traction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initial leakage pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pressure at catastrophic failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stroke events
Endpoint domain: Mortality/survival
Primary endpoint: Action item completion rates
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Satisfaction with hemostasis
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cumulative incidence of transient deficit of peripheral nerve
Endpoint domain: Adverse events/effects
Primary endpoint: Median NPq postoperative score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Postoperative delirium risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical response rates at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Alleviation of constipation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in clinical disease activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in endoscopic Crohn's disease severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unplanned visits to a healthcare provider
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Risk of RVF
Endpoint domain: Mortality/survival
Primary endpoint: Risk of NVF
Endpoint domain: Mortality/survival
Primary endpoint: Vertebral height lost rate (HLR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality or any major morbidity
Endpoint domain: Mortality/survival
Primary endpoint: incidence of moderate to severe bronchopulmonary dysplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: week 12 serum estradiol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: courses of oral corticosteroids
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Severity of age-related changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Reduction in enuresis frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of complicating VTA after AMI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Bucco-palatal width of the teeth
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative rate of GI SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: Cases of IBD
Endpoint domain: Adverse events/effects
Primary endpoint: postoperative drainage levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: improved HRQoL (Role Physical)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: improved HRQoL (Social Functioning)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Overall GI bleeding risk
Endpoint domain: Adverse events/effects
Primary endpoint: REM-RDI in the moderate/severe range (≥15 events/h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adherence to TSSE
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: TWC (Total Weekly Consumption)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain during S‐ICD placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single-pool Kt/V
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Time to reach undetectable viral RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Percentage of unprepared canal areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amount of dentine removed (mm3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: NMSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PDQ-8
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: LEDD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: load-induced cartilage biomarker response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dry eye symptomology improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tear film lipid layer thickness increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Meibomian gland capping improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Survival free from neurodisability
Endpoint domain: Mortality/survival
Primary endpoint: Mortality among infants weighing ≤1,500 g
Endpoint domain: Mortality/survival
Primary endpoint: No-show rates
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Guideline adherence in the management of Staphylococcus aureus infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Guideline adherence in sepsis management
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage excess weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: diabetes remission (HbA1c < 48 mmol/mol without medications)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Legal cynicism
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: work production
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Size of melasma reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of adequate immediate diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first treatment/intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of late pneumonia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mean change in knowledge score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: mean number of types of practiced behaviors
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Full or partial remission rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percent change in bone mineral density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean self-efficacy scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Morbidity of hypotension and bradycardia
Endpoint domain: Adverse events/effects
Primary endpoint: Volume threshold for drain removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative period for drain removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 1-year MACE
Endpoint domain: Mortality/survival
Primary endpoint: Improvement in cognition (especially memory)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Mean BDI-II scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Intentions to use the health service
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Willingness-to-wait
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Overall rating of masks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Comfort of masks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Donning of masks
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Return to play after surgery (RTPAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygenation (ratio of arterial oxygen partial pressure to fractional inspired oxygen)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: mycological eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Febrile Neutropenia (FN) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: task completion speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DASH pain and performing score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: DASH work ability score
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Scapula index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission of social anxiety disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CKMB values 12 hours post-op
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum malondialdehyde levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nitrate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Net monetary benefit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Nicotine gum use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Low-pitched voice symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tightness symptom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Irritated throat intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative thickness of subcutaneous fat tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age of onset of alcohol use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Age at first sexual intercourse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of probable bruxism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diagnosis of periodontitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AS cognitive concerns
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Asthma control status based on ACT scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Forced expiratory volume in the first second of expiration (PD20)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Measurement time for FOT vs APS-dosimeter
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Vaccine-associated pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ∆WID values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean time to optimal granulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost of treatment per patient
Endpoint domain: Resource use
Primary endpoint: Median visual acuity (VA) at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite of death, myocardial infarction, revascularisation, stroke
Endpoint domain: Mortality/survival
Primary endpoint: revascularisations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: clinical efficacy of PRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV-1 incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: N gonorrhoeae incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: C trachomatis incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: T vaginalis incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: degree of symptom reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: side‐effects' severity
Endpoint domain: Adverse events/effects
Primary endpoint: Total score on the Alzheimer's Disease Knowledge Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score on the Dementia Attitudes Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: PIVC survival until completion of therapy
Endpoint domain: Mortality/survival
Primary endpoint: milk spillover volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nurse satisfaction with feeding method
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: drain output at 23 h post operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: seroma incidence on days 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Mean systolic blood pressure increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean left ventricular ejection fraction reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Return to sport (in days)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Reinjury rates
Endpoint domain: Adverse events/effects
Primary endpoint: Mean change in nasal peak inspiratory flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Improvement in Rhinoconjunctivitis Quality of Life-36 Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: postoperative leg pain (NRS2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAR on MRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate of zirconia crowns
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parental overall satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number and duration of diurnal and nocturnal hot flashes (HFs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total score of MRS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCI (Geometric Coverage Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skin V103%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: ipsilateral lung V30%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: heart V5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: preservation in eGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinical Global Impression (CGI) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Substance Use Disorder (SUD) outcomes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: response bias for tactile stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-treatment FMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in LV mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Syndecan‐1 concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tympanic temperature elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory rate increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: screening positive for depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: screening positive for anxiety
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: screening positive for emotional distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: NDI-symptom checklist score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Disease Activity Score-28
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DMFT/dmft scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MOHRQoL-P scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of correct answers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achieved adequately informed status (>50% correct answers)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean blood glucose concentration peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: delay in blood glucose concentration peak
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Abstinence rates at 1, 4, and 12 months posttreatment
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Alcohol dependence severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence rate of first CLRD admission
Endpoint domain: Mortality/survival
Primary endpoint: Acceptance of screening for key populations
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: reduction of insomnia severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: social disabilities relating to social life
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: dysfunctional beliefs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Therapeutic response of RASi
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Protein targets reached ≥1.3 g/kgBW/d
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FSA-J score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Complete remission of ACVr HSV‐1 stomatitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction with sedation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Post-dialysis blood glucose levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in size of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in lesion's appearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in UDysRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent ON without troublesome dyskinesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Food insecurity rate in treatment households
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Very low food security rate among children in treatment households
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: NKC postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Pain Rating Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BOP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes